Vitaros Could Be Getting Approved In Switzerland Thanks To Apricus
Vitaros is a cream designed to be applied directly to the tip of the penis with a single-use applicator. The active ingredient of the cream, alprostadil, also known as PDE1, has been combined with specially developed high absorption molecules that allow the alprostadil to penetrate the skin and enter the bloodstream quickly. Because the cream uses an active ingredient different from such popular erectile dysfunction therapies as Viagra or Cialis, it may very well be a good alternative for those who have had limited success with pills. It is also associated with fewer and less severe side effects. The downside is that it must be stored in a refrigerator.
MORE ON VITAROS: A Drop of Vitaros PDE1 Applied Topically Can Help ED Fast
Apricus has applied for approval from Swissmedic for marketing Vitaros as an erectile dysfunction therapy in Switzerland. What has happened now is that Swissmedic has posed some additional questions. Apricus has filed an official response, thus starting Swissmedic’s 90-day review process. Suppose the answers filed by Apricus are found acceptable. In that case, a preliminary approval may be given, further questions may be asked, and Apricus would have to send in final labeling and pricing information, after which follows another 90-day review process and, hopefully, an approval. As for how many Swiss francs Apricus thinks Vitaros should sell for, they have not said, and previous statements have suggested 10-12 American dollars per dose.